Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

0.1547
-0.0028-1.78%
Post-market: 0.15550.0008+0.52%19:59 EDT
Volume:131.30M
Turnover:24.05M
Market Cap:75.65M
PE:-0.24
High:0.1695
Open:0.1695
Low:0.1450
Close:0.1575
52wk High:3.87
52wk Low:0.1138
Shares:489.00M
Float Shares:301.00M
Volume Ratio:11.26
T/O Rate:43.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6496
EPS(LYR):-0.7455
ROE:-783.37%
ROA:-62.39%
PB:-0.80
PE(LYR):-0.21

Loading ...

NASD Most Active Issues

Dow Jones
·
Yesterday

Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell

MT Newswires Live
·
Aug 21

Gossamer Bio, - Proceeds Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 21

Gossamer Bio, - $25 Mln Funded at Initial Closing, $125 Mln upon FDA Nda Acceptance

THOMSON REUTERS
·
Aug 21

Gossamer Bio Announces up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval

THOMSON REUTERS
·
Aug 21

Guggenheim Remains a Hold on Gossamer Bio (GOSS)

TIPRANKS
·
Aug 14

Gossamer Bio Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $9.238M Beat $5.193M Estimate

Benzinga Earnings
·
Aug 14

Gossamer Bio Q2 FY26 Returns to Profit at $16.9 Million; Revenue Falls 19.6% to $9.24 Million

Reuters
·
Aug 14

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

Gossamer Bio Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Gossamer Bio (GOSS) Receives a Hold from Wedbush

TIPRANKS
·
Jul 29

Leerink Partners Upgrades Gossamer Bio to Outperform From Market Perform, $1 Price Target

MT Newswires Live
·
Jul 28

Top Premarket Gainers

MT Newswires Live
·
Jul 28

U.S. Research Roundup- BioLife Solutions, Gossamer Bio, Intuit

Reuters
·
Jul 28

Gossamer Bio Inc : Leerink Partners Raises to Outperform from Market Perform

THOMSON REUTERS
·
Jul 28

Gossamer Bio upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Jul 28

NASD Most Active Issues

Dow Jones
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Gossamer Bio (GOSS)

TIPRANKS
·
Jul 28

Gossamer Bio Price Target Maintained with a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 28

Gossamer Bio Plans September New Drug Application Submission for Potential Pulmonary Arterial Hypertension Treatment

MT Newswires Live
·
Jul 27